Palacky University, Faculty of Physical Culture
Olomouc, Czech Republic, 77111, Czechia
NCT Number: NCT06951789
This trial evaluates the effect of molecular hydrogen inhalation on metabolic response, heart rate, and rating of perceived exertion in healthy females during 30 minutes of exercise on a bicycle ergometer.
Looking for future studies?
Notify Me18 year–35 year
Female
Interventional
Not applicable
Olomouc, Czech Republic, 77111, Czechia
The objective of this randomized, double-blind, placebo-controlled crossover trial is to assess the effect of molecular hydrogen inhalation on metabolic response during 20 min of rest and during exercise on a bicycle ergometer with a workload of 0.5 W/kg for 10 min, 0.75 W/kg for 10 min, and 1 W/kg for 10 min. The trial recruits healthy females aged 20-35 years and the planned sample size is 20. The trial consists of two experimental sessions, one using molecular hydrogen inhalation and the other using placebo inhalation. The washout period between sessions is one week. Randomization of the order of the sessions is performed using a computer random generator. Molecular hydrogen is produced using a hydrogen generator via electrolysis of water and administered through a mouthpiece. Ambient air is used for placebo inhalation. Molecular hydrogen is colorless, odorless, and tasteless, making it indistinguishable from placebo by the human senses. During the session, the following variables are measured: ventilation, oxygen uptake, respiratory exchange ratio, heart rate, rating of perceived exertion, and oxygen saturation. Energy expenditure, fat oxidation rate and carbohydrates oxidation rate are calculated from oxygen uptake and respiratory exchange ratio. Statistical analysis is performed at the 0.05 significance level and data are evaluated using analysis of variance for repeated measures with Fisher's post hoc tests.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Hydrogen gas, purity >99.9%, flow rate 600 ml/min (two generators 300 ml/min each).
Other names: i300 Hydrogen Generator, H2 World Health & Beauty Company, Ostrava, Czech Republic
Ambient air, flow rate 600 ml/min (two pumps 300 ml/min each).
Other names: i300 Hydrogen Generator (placebo), H2 World Health & Beauty Company, Ostrava, Czech Republic
Time frame: Change after 1 week of crossover.
Respiratory exchange ratio is measured with Ergostik analyser (Geratherm Respiratory, Bad Kissinger, Germany) breath by breath during the session and averaged over 5 min windows for subsequent analysis.
Time frame: Change after 1 week of crossover.
Ventilation is measured with Ergostik analyser (Geratherm Respiratory, Bad Kissinger, Germany) breath by breath during the session and averaged over 5 min windows for subsequent analysis.
Time frame: Change after 1 week of crossover.
Oxygen uptake is measured with Ergostik analyser (Geratherm Respiratory, Bad Kissinger, Germany) breath by breath during the session and averaged over 5 min windows for subsequent analysis.
Time frame: Change after 1 week of crossover.
Heart rate is recorded by Polar H10 chest strap (Polar, Kempele, Finland) during the session and averaged over 5 min windows for subsequent analysis.
Time frame: Change after 1 week of crossover.
Participants are asked to subjectively rate their perceived exertion at specified time points (at the end of rest, after 10, 20, and 30 min of exercise). The Borg's scale 6 (no exertion) and 20 (maximal exertion) is used.
Time frame: Change after 1 week of crossover.
Oxygen saturation is measured with pulse oximeter (Onyx Vantage 9590, Nonin Medical, Plymouth, MN) at specified time points (every 5 min at rest and every 2,5 min during exercise).
Palacky University
Other
Effect of Molecular Hydrogen Inhalation on Metabolic Response in Healthy Females During Low-intensity Exercise on a Bicycle Ergometer: A Randomized, Double-blind, Placebo-controlled Crossover Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT06702423
Healthy
London, United Kingdom
View Trial DetailsNCT07223164
Healthy
Irvine, California, United States
View Trial DetailsNCT05595902
Healthy
Kadıköy, Istanbul, Turkey (Türkiye)
View Trial Details